10,000
Participants
Start Date
May 7, 2019
Primary Completion Date
December 31, 2023
Study Completion Date
December 31, 2023
DyeVert™ Contrast Reduction Systems
Osprey Medical DyeVert™ Contrast Reduction Systems (DyeVert Systems) provide fluid pathway resistance modulation such that excess contrast media (CM) (i.e. CM that is not needed for diagnostic or therapeutic purposes) is minimized in the patient's vasculature and total contrast media volume (CMV) reduction occurs, while maintaining adequate image quality.
St. Mary's Medical Center, Huntington
West Virginia University, Morgantown
Atlanta VA Medical Center, Decatur
Emory Healthcare, Atlanta
Steward Palmetto General Hospital, Hialeah
North Mississippi Medical Center, Tupelo
St. Elizabeth Healthcare, Edgewood
Midwest Heart & Vascular Specialists, Overland Park
The University of Texas Health Science Center, San Antonio
CHRISTUS Health-Westover Hills, San Antonio
Hartford Healthcare, Hartford
Lead Sponsor
Osprey Medical, Inc
INDUSTRY